GENEVA, Sept. 18 -- PFIZER INC. (66 Hudson Boulevard EastNew York, New York 10001-2192) filed a patent application (PCT/IB2025/052355) for "IMPROVED LNP FORMULATIONS AND USES THEREOF" on Mar 04, 2025. With publication no. WO/2025/186725, the details related to the patent application was published on Sep 11, 2025.
Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).
Inventor(s): AGIANIAN, Bogos (c/o Pfizer Inc.445 Eastern Point Road, Building 98Groton, Connecticut 06340), ALLEN, Pirada Suphaphiphat (c/o Pfizer Inc.401 N. Middletown RoadPearl River, New York 10965), CAMPBELL, Adam Lee (c/o Pfizer Inc.401 N. Middletow...